#  Amy Yu 

Biological and Biomedical Sciences, Naama Kanarek Lab

 

 

 



   ![yu_amy_lcbrf_photo_.png](/sites/g/files/omnuum5431/files/styles/hwp_4_5__320x400/public/landrycancerbio/files/yu_amy_lcbrf_photo_.png?itok=tdk3md9v) 

 



 





 

Amy grew up in San Mateo, California and graduated in 2019 from the University of California, San Diego with a bachelor’s degree in Human Biology with honors. During her bachelor’s degree she conducted research in Dr. Amir Zarrinpar's lab, where she studied the cardiometabolic benefits of time-restricted feeding in atherosclerosis. To further develop her general interest in the integral role of cell metabolism in disease development, she worked as a research technician at the University of California, San Francisco in Dr. Jennifer Chen’s lab. Her project specifically focused on the anti-fibrotic therapeutic potential of acid ceramidase inhibition in nonalcoholic steatohepatitis (NASH)-induced liver fibrosis. Now, as a Ph.D. candidate in Dr. Naama Kanarek’s lab, Amy is investigating the compromised anti-tumor function of folate-deprived CD8 T cells.